Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
10.16(c) 10.11(c) 10.51(c) 10.26(c) 10.27(c) Last
640 215 389 709 623 637 388 239 568 996 Volume
+1.50% -0.49% +3.96% -2.38% +0.10% Change
More quotes
Financials ($)
Sales 2015 104 M
EBIT 2015 -42,1 M
Net income 2015 -46,0 M
Debt 2015 -
Yield 2015 -
Sales 2016 146 M
EBIT 2016 -18,9 M
Net income 2016 -25,7 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 4,12x
Capi. / Sales 2016 2,93x
Capitalization 429 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its product portfolio includes Fanapt and Tasimelteon.The Fanapt product is a compound for the treatment of schizophrenia, the... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
05/14 VANDA PHARMACEUTICALS : Reports First Quarter 2015 Financial Results
05/11 VANDA PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch 2015 Hea..
05/07 VANDA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
05/06 VANDA PHARMACEUTICALS : reports 1Q loss
05/06 VANDA PHARMACEUTICALS : Results of Operations and Financial Condition, Financial..
05/06 VANDA PHARMACEUTICALS : Reports First Quarter 2015 Financial Results
05/05 VANDA PHARMACEUTICALS : Other Events (form 8-K)
05/05 VANDA PHARMACEUTICALS : Early Briefing on Biotech Stocks -- Galena Biopharma, Is..
More news
Sector news : Bio Therapeutic Drugs
05/24 QUINTILES TRANSNATIONAL : Launches New Solution to Meet Needs of Asia-Pacific Em..
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/06 Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q1 2015 Results - ..
05/06 Vanda Pharmaceuticals beats by $0.15, beats on revenue
05/06 Vanda Pharmaceuticals (VNDA) Q1 2015 Results - Earnings Call Webcast
04/24 European Ad Comm backs Vanda's Hetlioz for sleep-wake disorder
03/05 Vanda Pharmaceuticals' Pipeline Goes Up In Smoke


Comments 
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions